The therapeutic potential of monoclonal antibodies against respiratory syncytial virus

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.7, Iss.8, 1998-08, pp. : 1271-1283

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prophylactic and Therapeutic Approaches Against Respiratory Syncytial Virus

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 1, 2005-01 ,pp. : 67-73

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Monoclonal Antibodies in Myocardial Reperfusion Injury

By Nigam A. Kopecky S.L.

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 6, 2002-01 ,pp. : 367-376

Adis International

Access to resources Recommend Favorite

Respiratory syncytial virus antiviral agents

By Prince G.A.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 6, 1999-06 ,pp. : 753-762

Informa Healthcare

Access to resources Recommend Favorite

Development of respiratory syncytial virus vaccines

Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The development of antiviral therapy and vaccines against respiratory syncytial virus and human parainfluenza virus type 3

By A J.E.

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 4, 2001-08 ,pp. : 175-190

Adis International

Access to resources Recommend Favorite